You just read:

Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol

News provided by

Regeneron Pharmaceuticals, Inc.

Aug 14, 2019, 07:00 ET